Causes and Risk Factors for Endometrial Cancer
Endometrial cancer, a type of uterine cancer, originates in the lining of the uterus, known as the endometrium. Understanding the factors that contribute to its development is crucial for prevention and early detection.
Key Takeaways
- Estrogen’s Influence: A hormonal environment with too much estrogen relative to progesterone — “unopposed” estrogen exposure — is the most consistently identified driver of endometrial cancer.
- Hormonal Imbalances: PCOS, early menarche, late menopause, never having been pregnant, and medications such as estrogen-only hormone therapy or tamoxifen all extend the body’s exposure to estrogen and raise risk.
- Lifestyle Factors: Excess weight, metabolic syndrome, and type 2 diabetes all contribute to risk, largely through their combined effects on estrogen and insulin.
- Genetic Predisposition: According to the National Cancer Institute, roughly 3%-5% of uterine cancer diagnoses trace back to an inherited cause, most often Lynch syndrome, which also raises the risk of colorectal and ovarian cancer.
- Risk-Reducing Steps: Managing weight, treating diabetes or PCOS, and discussing hormone therapy choices with a doctor are linked to lower risk, though not every case can be prevented.
What Causes Endometrial Cancer?
Endometrial cancer begins when malignant cells form in the endometrium, the tissue lining the inside of the uterus. At its core, the disease develops through a combination of genetic, hormonal, and environmental factors that disrupt the normal growth-and-shedding cycle of this lining.
Cellular Origins and Abnormal Growth
Endometrial cancer starts when a series of DNA changes builds up inside cells of the uterine lining, gradually loosening the checks that normally keep cell division in balance until a tumor forms. No single trigger explains every case, but the hormonal and metabolic factors described below are the most consistently observed contributors.
Estrogen’s Role in Endometrial Development
Estrogen normally stimulates the endometrium to thicken each month in preparation for a possible pregnancy. When estrogen levels stay elevated without enough progesterone to balance them — a pattern known as unopposed estrogen — the lining can become abnormally thick, a condition called endometrial hyperplasia. Hyperplasia itself isn’t cancer, though in a subset of cases it can develop into cancer over time. A hormonal environment weighted toward estrogen relative to progesterone is considered the most common underlying driver of endometrial cancer, and prolonged unopposed estrogen exposure can raise risk by roughly two- to twenty-fold, depending on how long the exposure lasts.
Hormonal Risk Factors for Endometrial Cancer
Because estrogen exposure plays such a central role, many of the established risk factors for this cancer come down to how much estrogen the body is exposed to, and for how long, relative to progesterone.
Estrogen Dominance and Imbalance
Several factors extend the body’s exposure to estrogen without adequate progesterone. Starting menstruation at an early age, reaching menopause later in life, and never having been pregnant all lengthen the time the endometrium is exposed to estrogen. Taking estrogen alone (without progesterone) as hormone therapy after menopause also raises risk, and longer use pushes that risk higher still; combining estrogen with progestin does not increase endometrial cancer risk, though it does raise the risk of breast cancer. Tamoxifen, prescribed to prevent or treat certain breast cancers, acts like estrogen on the uterus even as it blocks estrogen’s effects elsewhere in the body; using it for more than two years increases endometrial cancer risk, particularly in postmenopausal women.
Polycystic Ovary Syndrome (PCOS) and Anovulation
Polycystic ovary syndrome is a hormonal disorder marked by irregular or absent ovulation. Without regular ovulation, the body does not produce progesterone on a normal cycle, leaving the endometrium exposed to estrogen without its usual counterbalance. This is one reason PCOS is classified as an inherited condition linked to increased endometrial cancer risk.
Lifestyle and Health-Related Influences
Beyond direct hormone exposure, several health conditions and lifestyle factors influence endometrial cancer risk, often by affecting hormone levels.
Obesity and Metabolic Syndrome
Obesity is one of the most significant modifiable risk factors for endometrial cancer. It is tied to several other risk factors, including elevated estrogen levels, central body fat, polycystic ovary syndrome, and low levels of physical activity — all of which can raise risk. A related cluster of conditions — abdominal fat, high blood sugar, elevated blood pressure, and raised triglyceride levels, together known as metabolic syndrome — carries its own added risk. More broadly, carrying excess weight is one of several factors the CDC associates with a higher risk of many cancer types, cancer of the uterus among them.
Diabetes and Dietary Habits
Having type 2 diabetes may also raise the risk of endometrial cancer. Insulin resistance, a hallmark of type 2 diabetes, is thought to play a role, though diabetes and obesity frequently occur together, which can make it difficult to separate their individual contributions. The evidence on diet is less clear: the NCI found no proof that eating patterns built around produce or vitamin D alter this particular cancer risk, so weight and blood-sugar management remain the better-supported levers here.
Genetic Predisposition and Inherited Syndromes
Most endometrial cancer cases are not inherited, but genetics and family history play a meaningful role for a subset of women.
Lynch Syndrome (HNPCC)
Lynch syndrome — an older name for it is hereditary nonpolyposis colorectal cancer, or HNPCC — traces back to pathogenic changes in the DNA mismatch-repair (MMR) gene family, which includes MLH1, MSH2, MSH6, PMS2, plus EPCAM; carrying one of these changes raises the odds of several cancers, among them colorectal, ovarian, and endometrial cancer. According to NCI data, roughly 3%-5% of uterine cancer diagnoses trace back to an inherited cause, and Lynch syndrome itself is estimated to affect somewhere between 1 in 300 and 1 in 1,000 people in the general population, making it the main hereditary endometrial cancer syndrome. Endometrial cancer ranks as the second most typical cancer diagnosis in Lynch syndrome families, right behind colorectal cancer, and women with the condition tend to be diagnosed earlier than average, at a median age of 48. For people with a personal or family pattern suggestive of Lynch syndrome, genetic counseling and diagnostic testing are recommended.
Family History Considerations
Even without a diagnosed genetic syndrome, a first-degree relative history of the disease — in a mother, sister, or daughter — is linked to increased risk. Other inherited conditions, such as Cowden syndrome, have also been tied to higher endometrial cancer risk, though they are far less common than Lynch syndrome. Individuals with a strong family history of endometrial, ovarian, or colorectal cancer should discuss that history with their healthcare provider to understand their personal risk and whether genetic counseling is appropriate.
Frequently Asked Questions
Can endometrial cancer be prevented?
Not every case can be prevented, but several factors are linked to lower risk: maintaining a healthy weight, staying physically active, and managing conditions such as type 2 diabetes or PCOS. Combined hormonal contraceptives and having been pregnant are also linked to reduced risk. It’s worth discussing the risks and benefits of any hormone therapy with a doctor, since the type used can affect endometrial cancer risk.
How common is endometrial cancer?
Among the two forms of uterine cancer, endometrial cancer is by far the more common one, and it typically develops after menopause. There is no way to know in advance who will develop it, and some women who develop it have no identifiable risk factors.
What are the early signs of endometrial cancer?
The single most telling early warning sign is unusual bleeding from the vagina, particularly once a woman is past menopause; this symptom is why most cases are caught at an early, highly treatable stage. Any unexpected bleeding is worth reporting to a doctor promptly.
Sources
